Fusion Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.466; its P/E ratio is -14.60; Fusion Pharmaceuticals is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	$ 2.01M	$ 34.00K	$ 28.00K	$ 140.00K
Gross Profit	-	$ 2.01M	$ 34.00K	$ 28.00K	$ 140.00K
EBIT	$ -25.55M	$ -16.18M	$ -24.14M	$ -23.08M	$ -25.10M
EBITDA	$ -22.21M	$ -16.19M	$ -25.29M	$ -23.91M	-
Net Income Common Stockholders	$ -28.18M	$ -17.25M	$ -25.18M	$ -24.29M	$ -24.62M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 233.61M	$ 191.35M	$ 198.10M	$ 209.84M	$ 170.87M
Total Assets	$ 285.84M	$ 253.38M	$ 268.29M	$ 266.55M	$ 219.06M
Total Debt	$ 50.56M	$ 52.63M	$ 50.62M	$ 50.06M	$ 40.25M
Net Debt	$ -183.05M	$ -138.72M	$ -147.47M	$ -159.78M	$ -130.62M
Total Liabilities	$ 63.36M	$ 64.91M	$ 65.33M	$ 65.72M	$ 56.84M
Stockholders Equity	$ 222.48M	$ 188.47M	$ 202.96M	$ 200.83M	$ 162.22M
Cash Flow	-
Free Cash Flow	$ -19.43M	$ -19.31M	$ -20.29M	$ -26.66M	$ -20.31M
Operating Cash Flow	$ -17.94M	$ -18.84M	$ -19.58M	$ -25.43M	$ -19.36M
Investing Cash Flow	$ -5.24M	$ 13.33M	$ -26.32M	$ -24.53M	$ -42.93M
Financing Cash Flow	$ 57.85M	$ 328.00K	$ 24.31M	$ 59.52M	$ 131.00K

Currency in USD

Fusion Pharmaceuticals Earnings and Revenue History

Income Statement >

Fusion Pharmaceuticals Debt to Assets

Balance Sheet >

Fusion Pharmaceuticals Cash Flow

Cash Flow >

Fusion Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing